High Total Cholesterol in Primary Biliary Cholangitis cases tied to poor clinical outcomes Aditi22 Feb 2024 3:30 AM ISTPatients with primary biliary cholangitis (PBC) often have hypercholesterolemia. However, its association with prognosis and lipid metabolism remains...
Novel oral intragastric expandable capsules can revolutionize weight loss management in obese patients: Study Medha Baranwal20 Feb 2024 6:00 PM ISTChina: A recent study published in Diabetes, Obesity and Metabolism has shed light on the safety and efficacy of intragastric expandable oral capsules...
Pfizer gets EU nod for ulcerative colitis drug Velsipity Ruchika Sharma20 Feb 2024 11:30 AM ISTThe approval, applicable in all 27 countries of the European Union, is based on studies from two late-stage trials that showed the drug was effective...
Low iron levels closely associated with higher risk of coeliac disease: BMJ Jacinthlyn Sylvia19 Feb 2024 6:00 PM ISTA recent study explored the complex interplay between genetics and health and uncovered a potential environmental trigger for the rising prevalence of...
Study reveals alarming rise in the incidence of gastric outlet obstruction due to NSAIDs and opioid abuse in North West India Medha Baranwal19 Feb 2024 6:00 AM ISTIndia: A recent study published in JAPI: Journal of the Association of Physicians of India has shed light on the alarming incidence of gastric outlet...
Tradipitant Shows Promise in Alleviating Nausea in Gastroparesis Dr Riya Dave15 Feb 2024 10:00 AM ISTNeurokinin receptor 1 (NK1R) antagonists have shown efficacy in reducing nausea and vomiting in various conditions, including chemotherapy-induced...
SGLT2 inhibitors preferred oral antidiabetic for individuals with both NAFLD and T2D,reveals study Dr Riya Dave15 Feb 2024 9:30 AM ISTNonalcoholic fatty liver disease (NAFLD) is prevalent among individuals with type 2 diabetes (T2D) and presents a significant health burden. While...
FDA approves budesonide oral suspension for treatment of eosinophilic esophagitis Dr. Kamal Kant Kohli14 Feb 2024 10:00 AM ISTThe Food and Drug Administration (FDA) has approved EOHILIA (budesonide) oral suspension for treatment of eosinophilic esophagitis among adults and...
Takeda Eohilia gets USFDA nod for people aged 11 years and older with eosinophilic esophagitis Ruchika Sharma13 Feb 2024 1:30 PM ISTOsaka: Takeda has announced that the U.S. Food and Drug Administration (FDA) has approved EOHILIA (budesonide oral suspension), the first and...
Saffron Promising in Reducing the Symptoms of Ulcerative Colitis: Study Jacinthlyn Sylvia12 Feb 2024 9:15 PM ISTA study conducted at Yazd University explored the therapeutic benefits of saffron as an additional intervention to improve clinical manifestations in...
GSK gets USFDA Fast Track designation for Bepirovirsen in chronic hepatitis B Ruchika Sharma12 Feb 2024 3:30 PM ISTLondon: GSK plc has announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for bepirovirsen, an...
Prophylactic pancreatic stent in addition to rectal indomethacin effective for preventing post-ERCP pancreatitis Dr Riya Dave11 Feb 2024 6:00 PM ISTEndoscopic retrograde cholangiopancreatography (ERCP) is a valuable diagnostic and therapeutic procedure, but it comes with the risk of pancreatitis,...
